IFN beta 1b induced celiac disease

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 12, 2011, Pages 1525-1526

  Fernndez Salazar, Luis ^a   Lvarez Quiones, Mara ^a   Gonzlez Hernndez, José Manuel ^a   Fraile, Adela ^a   Mayor, Eduardo ^a   Arranz, Eduardo ^b   Garrote, José Antonio ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIBODY; GLATIRAMER; HLA DQ2 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; INTERFERON BETA SERINE; INTERLEUKIN 17; METHYLPREDNISOLONE; RECOMBINANT ALPHA INTERFERON; RIBAVIRIN;

ABDOMINAL PAIN; ADULT; CASE REPORT; CELIAC DISEASE; CYTOKINE PRODUCTION; DIARRHEA; DIGESTION; DRUG DOSE INCREASE; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; DUODENUM BIOPSY; FEMALE; GENETIC SUSCEPTIBILITY; GLUTEN FREE DIET; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MULTIPLE SCLEROSIS; NAUSEA; PRIORITY JOURNAL; SIDE EFFECT; TH1 CELL; ULCERATIVE COLITIS;

ADULT; CELIAC DISEASE; FEMALE; HLA-DQ ANTIGENS; HUMANS; INTERFERON-BETA; MULTIPLE SCLEROSIS;

EID: 80655142456     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2011.613950     Document Type: Letter

References (9)

1. Rodrigo L, Hernandez-Lahoz C, Fuentes D, Alvarez N, Lopez-Vazquez A, Gonzalez S. Prevalence of celiac disease in multiple sclerosis. BMC Neurol 2011;11:31.
2. Nunez C, Dema B, Cenit MC, Polanco I, Maluenda C, Arroyo R, et al. IL23R: a susceptibility locus for celiac disease and multiple sclerosis? Genes Immun 2008;9:289-93. (Pubitemid 351791483)
3. Cammarota G, Cuoco L, Cianci R, Pandolfi F, Gasbarrini G. Onset of coeliac disease during treatment with interferon for chronic hepatitis C. Lancet 2000;356: 1494-5.
4. Sprenger R, Sagmeister M, Offner F. Acute ulcerative colitis during successful interferon/ribavirin treatment for chronic hepatitis. Gut 2005;54:438-9; author reply 9. (Pubitemid 40299105)
5. Watanabe T, Inoue M, Harada K, Homma N, Uchida M, Ogata N, et al. A case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon alpha-2b and ribavirin. Gut 2006;55: 1682-3. (Pubitemid 44629245)
6. Musch E, Andus T, Kruis W, Raedler A, Spehlmann M, Schreiber S, et al. Interferon-beta-1a for the treatment of steroid-refractory ulcerative colitis: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2005;3:581-6. (Pubitemid 40824751)
7. Rodrigues S, Magro F, Soares J, Nunes AC, Lopes S, Marques M, et al. Case series: ulcerative colitis, multiple sclerosis, and interferon-beta 1a. Inflamm Bowel Dis 2010; 16:2001-3.
8. Mannon PJ, Hornung RL, Yang Z, Yi C, Groden C, Friend J, et al. Suppression of inflammation in ulcerative colitis by interferon-beta-1a is accompanied by inhibition of IL-13 production. Gut 2011;60:449-55.
9. Di Sabatino A, Pickard KM, Gordon JN, Salvati V, Mazzarella G, Beattie RM, et al. Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease. Gastroenterology 2007;133: 1175-87. (Pubitemid 47494463)